{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T09:17:28Z","timestamp":1777713448135,"version":"3.51.4"},"reference-count":42,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":4485,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["li.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Laboratory Investigation"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1038\/labinvest.2010.95","type":"journal-article","created":{"date-parts":[[2010,5,17]],"date-time":"2010-05-17T10:32:12Z","timestamp":1274092332000},"page":"1482-1491","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["IFN-\u03ba, a novel type I IFN, is undetectable in HPV-positive human cervical keratinocytes"],"prefix":"10.1016","volume":"90","author":[{"given":"Correne A","family":"DeCarlo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Severini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lutz","family":"Edler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas G","family":"Escott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul F","family":"Lambert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"Ulanova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingeborg","family":"Zehbe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1038\/labinvest.2010.95_bib1","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1056\/NEJMoa044397","article-title":"A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis","volume":"354","author":"Polman","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1038\/labinvest.2010.95_bib2","unstructured":"De Maeyer E, De Maeyer-Guignard J. Interferons. In: Thompson A (ed.) The Cytokine Handbook, 3rd edn., Academic Press: San Diego, CA, USA, pp 491\u2013516."},{"key":"10.1038\/labinvest.2010.95_bib3","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1177\/000348940511400608","article-title":"Use of interferon-alpa in recurrent repiratory papillomatosis: 20 year follow-up","volume":"114","author":"Gerein","year":"2005","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1038\/labinvest.2010.95_bib4","first-page":"5","article-title":"An evidence-based review of medical and surgical treatment of genital warts","volume":"12","author":"Scheinfeld","year":"2006","journal-title":"Dermatol Outline J"},{"key":"10.1038\/labinvest.2010.95_bib5","first-page":"258","article-title":"Virus interference I. The interferon","volume":"147","author":"Isaacs","year":"1957","journal-title":"Proc R Soc"},{"key":"10.1038\/labinvest.2010.95_bib6","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/nature01850","article-title":"Integration of interferon-\u03b1\/\u03b2 signalling to p53 responses in tumor suppression and antiviral defence","volume":"424","author":"Takaoka","year":"2003","journal-title":"Nature"},{"key":"10.1038\/labinvest.2010.95_bib7","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.immuni.2006.08.007","article-title":"Type I interferons and host defense","volume":"25","author":"Stetson","year":"2006","journal-title":"Immunity"},{"key":"10.1038\/labinvest.2010.95_bib8","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1146\/annurev.bi.56.070187.003455","article-title":"Interferons and their actions","volume":"56","author":"Pestka","year":"1987","journal-title":"Annu Rev Biochem"},{"key":"10.1038\/labinvest.2010.95_bib9","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1146\/annurev.immunol.15.1.563","article-title":"The IFN receptor: a paradigm for cytokine receptor signaling","volume":"15","author":"Bach","year":"1997","journal-title":"Annu Rev Immunol"},{"key":"10.1038\/labinvest.2010.95_bib10","doi-asserted-by":"crossref","first-page":"39765","DOI":"10.1074\/jbc.M102502200","article-title":"Interferon-\u03ba, a novel type I interferon expressed in human keratinocytes","volume":"276","author":"Lafleur","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1038\/labinvest.2010.95_bib11","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1089\/jir.2006.26.40","article-title":"Antiviral activity of transiently expressed IFN-\u03ba is cell-associated","volume":"52","author":"Buontempo","year":"2006","journal-title":"J Inter Cyto Res"},{"key":"10.1038\/labinvest.2010.95_bib12","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/S0140-6736(01)06102-5","article-title":"Albrecht Interferon alfa-2b plus ribavirin compared with interferon alfa2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial","volume":"358","author":"Manns","year":"2001","journal-title":"Lancet"},{"key":"10.1038\/labinvest.2010.95_bib13","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1089\/jir.2006.26.133","article-title":"Analysis of IFN-\u03ba expression in pathological skin conditions: downregulation in psoriasis and atopic dermatitis","volume":"26","author":"Scarponi","year":"2006","journal-title":"J Inter Cyto Res"},{"key":"10.1038\/labinvest.2010.95_bib14","doi-asserted-by":"crossref","first-page":"6764","DOI":"10.1074\/jbc.275.10.6764","article-title":"Inactivation of interferon regulator factor-1 tumor suppressor protein by HPV E7 oncoprotein","volume":"275","author":"Park","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1038\/labinvest.2010.95_bib15","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1101\/gad.12.13.2061","article-title":"Human papillomavirus 16 E6 oncoprotein binds to interferon regulatory factor-3 and inhibits its transcriptional activity","volume":"12","author":"Ronco","year":"1998","journal-title":"Genes Dev"},{"key":"10.1038\/labinvest.2010.95_bib16","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1006\/viro.1999.9771","article-title":"The human papillomavirus E7 oncoprotein abrogates signalling mediated by interferon-alpha","volume":"259","author":"Barnard","year":"1999","journal-title":"Virology"},{"key":"10.1038\/labinvest.2010.95_bib17","doi-asserted-by":"crossref","first-page":"5727","DOI":"10.1038\/sj.onc.1202960","article-title":"The human papilloma vrus (HPV)-18 E6 oncoprotein physically associates with Tyk2 and impairs Jak-STAT activation by interferon-\u03b1","volume":"18","author":"Li","year":"1999","journal-title":"Oncogene"},{"key":"10.1038\/labinvest.2010.95_bib18","doi-asserted-by":"crossref","first-page":"4174","DOI":"10.1128\/JVI.74.9.4174-4182.2000","article-title":"Microarray analysis identifies interferon-inducible genes and stat-1 as major transcriptional targets of human papillomavrus type 31","volume":"74","author":"Chang","year":"2000","journal-title":"J Virol"},{"key":"10.1038\/labinvest.2010.95_bib19","doi-asserted-by":"crossref","first-page":"4283","DOI":"10.1128\/JVI.75.9.4283-4296.2001","article-title":"Papillomavirus type 16 oncogenes downregulate expression of interferon-responsive genes and upregulate proliferation-associated and NF-kB-responsive genes in cervical keratinocytes","volume":"75","author":"Nees","year":"2001","journal-title":"J Virol"},{"key":"10.1038\/labinvest.2010.95_bib20","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1128\/JVI.76.1.280-291.2002","article-title":"Disturbance of tumor necrosis factor alpha-mediated beta interferon signalling in cervical carcinoma cells","volume":"76","author":"Bachmann","year":"2002","journal-title":"J Virol"},{"key":"10.1038\/labinvest.2010.95_bib21","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/S0959-8049(98)00371-2","article-title":"Differences in cytokine mRNA profiles between premalignant and malignant lesions of the uterine cervix","volume":"35","author":"de Gruijl","year":"1999","journal-title":"Eur J Cancer"},{"key":"10.1038\/labinvest.2010.95_bib22","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0959-8049(02)00839-0","article-title":"Identification and characterisation of a group of cervical carcinoma patients with profound downregulation of intratumoral type I (IFN-\u03b3) and type 2 (IL-4) cytokine mRNA expression","volume":"39","author":"Gey","year":"2003","journal-title":"Eur J Cancer"},{"key":"10.1038\/labinvest.2010.95_bib23","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1128\/JCM.38.1.357-361.2000","article-title":"Improved amplification of genital human papillomaviruses","volume":"38","author":"Gravitt","year":"2000","journal-title":"J Clin Microbiol"},{"key":"10.1038\/labinvest.2010.95_bib24","series-title":"Proceedings from the Canadian Association for Clinical Microbiology and Infectious Diseases Annual Conference","article-title":"The Canadian Women's HIV Study Group. A microsphere based multiplexed assay for genotyping 46 mucosal human papillomavirus types.","author":"Goleski","year":"2007"},{"key":"10.1038\/labinvest.2010.95_bib25","series-title":"Proceedings from the European Research Organisation on Genital Infection and Neoplasia Conference","article-title":"Luminex-based assay for multiplex genotyping of 45 mucosal human papillomavirus types","author":"Goleski","year":"2008"},{"key":"10.1038\/labinvest.2010.95_bib26","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/BF00200657","article-title":"Detection of human papillomavirus in cervical intra-epithelial neoplasia, using in situ hybridization and various polymerase chain reaction techniques","volume":"428","author":"Zehbe","year":"1996","journal-title":"Virchows Arch"},{"key":"10.1038\/labinvest.2010.95_bib27","series-title":"Microorganisms","first-page":"55","article-title":"Cellular pathology techniques","author":"Culling","year":"1985"},{"key":"10.1038\/labinvest.2010.95_bib28","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1046\/j.1523-1747.2000.00869.x","article-title":"Normal growth and differentiation in a spontaneously immortalized near-diploid human keratinocyte cell line, NIKS","volume":"114","author":"Allen-Hoffmann","year":"2000","journal-title":"J Invest Dermatol"},{"key":"10.1038\/labinvest.2010.95_bib29","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.virol.2008.09.036","article-title":"Human papillomavirus 16 E6 variants in their dysregulation of human keratinocyte differentiation and apoptosis","volume":"383","author":"Zehbe","year":"2009","journal-title":"Virol"},{"key":"10.1038\/labinvest.2010.95_bib30","doi-asserted-by":"crossref","first-page":"6622","DOI":"10.1128\/JVI.74.14.6622-6631.2000","article-title":"The human papillomavirus type 16 E7 oncogene is required for the productive stage of the viral life cycle","volume":"74","author":"Flores","year":"2000","journal-title":"J Virol"},{"key":"10.1038\/labinvest.2010.95_bib31","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ab.2008.06.009","article-title":"Gene expression analysis of interferon kappa in laser capture microdissected cervical epithelium","volume":"381","author":"DeCarlo","year":"2008","journal-title":"Anal Biochem"},{"key":"10.1038\/labinvest.2010.95_bib32","series-title":"Statistical Methods for Rates and Proportions","author":"Fleiss","year":"2003"},{"key":"10.1038\/labinvest.2010.95_bib33","series-title":"Nonparametric Statistical Methods","author":"Hollander","year":"1999"},{"key":"10.1038\/labinvest.2010.95_bib34","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1099\/vir.0.83586-0","article-title":"Altered expression of UVB-induced cytokines in human papillomavirus-immortalized epithelial cells","volume":"89","author":"Dell'Oste","year":"2008","journal-title":"J Gen Virol"},{"key":"10.1038\/labinvest.2010.95_bib35","doi-asserted-by":"crossref","first-page":"d2058","DOI":"10.2741\/woodworth","article-title":"HPV innate immunity","volume":"7","author":"Woodworth","year":"2002","journal-title":"Front Biosci"},{"issue":"16","key":"10.1038\/labinvest.2010.95_bib36","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1038\/onc.2010.9","article-title":"Peptide-based interference of the transmembrane domain of neuropilin-1 inhibits glioma growth in vivo","volume":"29","author":"Nasarre","year":"2010","journal-title":"Oncogene"},{"key":"10.1038\/labinvest.2010.95_bib37","doi-asserted-by":"crossref","first-page":"8718","DOI":"10.1158\/0008-5472.CAN-09-0550","article-title":"Epigenetic silencing of interferon-\u03ba in human papillomavirus type 16-positive cells","volume":"69","author":"Rincon-Orozco","year":"2009","journal-title":"Cancer Res"},{"key":"10.1038\/labinvest.2010.95_bib38","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1128\/jvi.63.6.2785-2789.1989","article-title":"Bacterial lipopolysaccharide and gamma interferon induce transcription of beta interferon mRNA and interferon secretion in murine macrophages","volume":"63","author":"Gessani","year":"1989","journal-title":"J Virol"},{"key":"10.1038\/labinvest.2010.95_bib39","doi-asserted-by":"crossref","first-page":"4822","DOI":"10.4049\/jimmunol.169.9.4822","article-title":"Regulatory effect of IFN-\u03ba, a novel type I IFN, on cytokine production by cells of the innate immune system","volume":"169","author":"Nardelli","year":"2002","journal-title":"J Immunol"},{"key":"10.1038\/labinvest.2010.95_bib40","doi-asserted-by":"crossref","first-page":"5748","DOI":"10.4049\/jimmunol.170.11.5748","article-title":"Expression of a novel murine type I IFN in the pancreatic islets induces diabetes in mice","volume":"170","author":"Vassileva","year":"2003","journal-title":"J Immunol"},{"key":"10.1038\/labinvest.2010.95_bib41","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/path.929","article-title":"Quantitative analysis of IL-10 and IFN-gamma mRNA levels in normal cervix and human papillomavirus type16 associated cervical precancer","volume":"195","author":"El-Sherif","year":"2001","journal-title":"J Path"},{"key":"10.1038\/labinvest.2010.95_bib42","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/jnci\/89.3.245","article-title":"Cytokine production patterns in cervical intraepithelial neoplasia: association with human papillomavirus infection","volume":"89","author":"Clerici","year":"1997","journal-title":"J Nat Cancer Inst"}],"container-title":["Laboratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/labinvest201095.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/labinvest201095","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0023683722028574?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0023683722028574?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/labinvest201095.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T19:52:55Z","timestamp":1758397975000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0023683722028574"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":42,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["S0023683722028574"],"URL":"https:\/\/doi.org\/10.1038\/labinvest.2010.95","relation":{},"ISSN":["0023-6837"],"issn-type":[{"value":"0023-6837","type":"print"}],"subject":[],"published":{"date-parts":[[2010,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IFN-\u03ba, a novel type I IFN, is undetectable in HPV-positive human cervical keratinocytes","name":"articletitle","label":"Article Title"},{"value":"Laboratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/labinvest.2010.95","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2010 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}